Cancer Cell
Volume 31, Issue 2, 13 February 2017, Pages 270-285
ArticleMYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
MYC
genetically engineered mouse model
neuroendocrine
small-cell lung cancer
Aurora kinase inhibitor
chemotherapy
ASCL1
NEUROD1
Cited by (0)
© 2016 Elsevier Inc.